These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Goals of treatment for osteoporosis].
    Author: Nakamura T.
    Journal: Clin Calcium; 2008 Oct; 18(10):1389-95. PubMed ID: 18830034.
    Abstract:
    Clinical practice is based on the data obtained in the randomized clinical trials with robust statistical power. Results of meta-analysis including plural randomized trials are also reliable, directly indicating the consistency of the efficacy of the treatment. Osteoporosis, a reduction in bone strength, is a disease of increased fracture risk, leading to enforced morbidity due to chronic pain and skeletal deformity and consequent increase in mortality. Thus, the reduction in fracture risk is just a prerequisite, and the decreases in morbidity and mortality are expected as the further goal of osteoporosis treatment. Evidences have been accumulated to indicate that treatments with amino-bisphosphonates reduce fracture risk, maintain ADL and QOL, and decrease the death rates. Osteoporosis treatment is greatly recommended to improve the general health condition in elderly people.
    [Abstract] [Full Text] [Related] [New Search]